Literature DB >> 11270948

[Changes in the levels of acute phase proteins in viral hepatitis].

E V Volchkova, S G Pak, V A Malov, K T Umbetova.   

Abstract

AIM: To investigate changes in the levels of acute phase proteins (APP) in the serum of patients with acute and chronic viral hepatitis of various etiology.
MATERIAL AND METHODS: APP (prealbumin, albumin, transferrin, haptoglobin) were measured by automatic kinetic analyzer JCS II TM (Beckman) in 92 patients with acute and 61 patients with chronic viral hepatitis. Synthesis of albumin, prealbumin was depressed, of haptoglobin increased in patients with acute viral hepatitis irrespective of etiology at the height of intoxication. In chronic viral diseases APP content depended on the disease etiology. In chronic hepatitis C, B + C and D albumin, haptoglobin and transferrin were low in clinical exacerbation while in patients with chronic hepatitis B a fall in albumin, prealbumin and transferrin is accompanied with high haptoglobin.
CONCLUSION: A complicated multidirectional changes in APP in patients with acute or chronic hepatitis serve, on the one hand, an integral diagnostic indication of hepatic function in conditions of systemic endotoxemia. On the other hand, endotoxemia is caused by lipopolysaccharides of gram-negative bacteria entering blood flow in great amounts in morphofunctional hepatic disorders caused by viral hepatitis of different etiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11270948

Source DB:  PubMed          Journal:  Ter Arkh        ISSN: 0040-3660            Impact factor:   0.467


  2 in total

1.  Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.

Authors:  Yin-Rong Yang; Shi-Lian Liu; Zhao-Yu Qin; Fu-Jun Liu; Yan-Jiang Qin; Shu-Mei Bai; Zhe-Yu Chen
Journal:  Cell Mol Neurobiol       Date:  2008-03-15       Impact factor: 5.046

2.  Predictive role of acute phase reactants in the response to therapy in patients with chronic hepatitis C virus infection.

Authors:  Ayten Oguz; Ahmet Engin Atay; Adnan Tas; Gulseren Seven; Mehmet Koruk
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.